Health Products

Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity

· Published by Health Canada · Official notice

Details

Alert type: Public advisory
Category: Health products - Drugs
Product: Apo-Acyclovir (acyclovir) 200 mg and 800 mg tablets
Issue: Health products - Contamination
What to do: Continue taking your medication unless you have been advised to stop by your health care provider. You do not need to return your medication to your pharmacy. Not treating your condition may pose a greater health risk.
Audience: General public
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

LotCompanyDINProductExpiry
RT8943Apotex Inc.02207656Apo-Acyclovir 800 mg07/2022
RP8516Apotex Inc.02207656Apo-Acyclovir 800 mg07/2022
RP8517Apotex Inc.02207656Apo-Acyclovir 800 mg07/2022
RH9368Apotex Inc.02207621Apo-Acyclovir 200 mg08/2022
RH9370Apotex Inc.02207621Apo-Acyclovir 200 mg08/2022

Issue

UPDATE (July 28, 2022): Update: Apotex recalls additional Apo-Acyclovir tablets due to a nitrosamine impurity Apotex Inc. is recalling four additional lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above or close to the acceptable level.. Apo-Acyclovir is a prescription antiviral drug used to treat shingles, and to treat or reduce the recurrence of genital herpes. The Affected Products table has been updated with detailed information on the recalled lots. Should any additional recalls be necessary, Health Canada will update the table and inform Canadians.

Original Advisory (2022-04-28): Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level.

Apo-Acyclovir is a prescription antiviral drug used to treat shingles, and to treat or reduce the recurrence of genital herpes.

NDMA is classified as a probable human carcinogen. This means that long-term exposure to a level above what is considered acceptable may increase the risk of cancer. We are all exposed to low levels of nitrosamines through a variety of foods (such as smoked and cured meats, dairy products and vegetables), drinking water and air pollution. This impurity is not expected to cause harm when ingested at or below the acceptable level. A person taking a drug that contains this impurity at or below the acceptable level every day for 70 years is not expected to have an increased risk of cancer.

Patients can continue to take their medication as prescribed by their health care provider and do not need to return their medication to their pharmacy, but they should contact their health care provider if they have taken the recalled product and are concerned about their health.

There is no immediate risk in continuing to take the recalled medication, since the increased risk of cancer typically involves long-term exposure to the nitrosamine impurity above the acceptable level.

Health Canada is monitoring the effectiveness of the recall and the company’s implementation of any necessary corrective and preventative actions. Should any additional recalls be deemed necessary, Health Canada will update the table and inform Canadians.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime